Melissaridou et al. showed head and neck squamous cell carcinoma cell line LK0902 was more sensitive to cetuximab, which is an epidermal growth factor receptor (EGFR) inhibitor in 3D conditions compared to 2D [30]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.